post-add

Sun Pharma Earns Spot In S&P Global Sustainability Yearbook 2024

Sun Pharmaceutical Industries (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) and its subsidiaries in a press statement on Monday announced their inclusion in the prestigious S&P Global Sustainability Yearbook 2024. Released on February 12, 2024, the Yearbook is designed to identify and celebrate companies within their respective industries that have showcased outstanding commitment to corporate sustainability.

Dilip Shanghvi, the Managing Director of Sun Pharma, expressed his views on this accomplishment, stating, "Sun Pharma continues to focus on delivering sustainable outcomes for all our stakeholders. Sustainability is an integral part of our way of doing business. We are guided by a clear roadmap around our ESG priorities, and the S&P Yearbook inclusion is a testament to our progress on the roadmap."

The recognition is based on the S&P Global Corporate Sustainability Assessment (CSA) for the year 2023, which rigorously evaluated more than 9,400 companies globally for The Sustainability Yearbook 2024. Out of this extensive pool, a distinguished group of 739 companies, including Sun Pharma, secured their places in the prestigious Yearbook.

Also Read

Subscribe to our newsletter to get updates on our latest news